CurrentCardio coverage · page 15 of 15
European Journal of Heart Failure
Latest from European Journal of Heart Failure
Eur J Heart Fail
Eur J Heart Fail
Eur J Heart Fail
Eur J Heart Fail
Eur J Heart Fail
Evolocumab has no Effects on Heart Failure with Reduced Ejection Fraction Injury Biomarkers: The EVO-HF Trial
Randomised controlled trialHeart failure
Eur J Heart Fail
Hypoxaemia in Patients with Heart Failure and Preserved Ejection Fraction
Cross-sectional studyHeart failure
Eur J Heart Fail
Eur J Heart Fail
Eur J Heart Fail
Eur J Heart Fail
Eur J Heart Fail
Eur J Heart Fail
Eur J Heart Fail
Eur J Heart Fail
Eur J Heart Fail
Incremental Prognostic Value of Biomarkers in PARADIGM-HF
Secondary analysisHeart failure
Eur J Heart Fail
Eur J Heart Fail
Eur J Heart Fail
Eur J Heart Fail
Eur J Heart Fail
Time to Benefit of Heart Rate Reduction with Ivabradine in Patients with Heart Failure and Reduced Ejection Fraction
Secondary analysisHeart failure
Eur J Heart Fail
Eur J Heart Fail
Sodium and Potassium Changes During Decongestion with Acetazolamide – A Pre-Specified Analysis from the ADVOR Trial
Secondary analysisHeart failure
Eur J Heart Fail
Empagliflozin in Heart Failure with Preserved Ejection Fraction with and without Atrial Fibrillation
Secondary analysisHeart failure
Eur J Heart Fail
Eur J Heart Fail
Diagnostic Value of Reduced Left Atrial Compliance During Ergometry Exercise in Heart Failure with Preserved Ejection Fraction
Diagnostic or prognostic studyHeart failure
Eur J Heart Fail
Biventricular Cardiac Power Reserve in Heart Failure with Preserved Ejection Fraction
Cohort studyHeart failure
Eur J Heart Fail
Potential Global Impact of Sodium–Glucose Cotransporter-2 Inhibitors in Heart Failure
Research articleHeart failure
Eur J Heart Fail
Health Status Across Major Subgroups of Patients with Heart Failure and Preserved Ejection Fraction
Secondary analysisHeart failure